EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Adia Nutrition Inc (ADIA) fair value: what the stock is really worth

We calculate from audited financials what Adia Nutrition Inc is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

Valuation from Jun 23, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.
  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Financial Services · US · ISIN US00687W1099

AN Adia Nutrition Inc logo Thin data Jun 23, 2026

Adia Nutrition Inc

ADIA · US

Weakest SetupStrongly overvalued and low quality.

!Fair value $0.0200 · Strongly overvalued (−84%)
!Quality 44/100
!Weak Growth
!Loss-making · -54.9% net margin (TTM)
!Negative equity (buybacks among others) · negative free cash flow
!Trails peers (2/7)
!Narrow moat 2/100
!Evidence only low, so the estimate is less certain

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$0.2440 $0.0010 Fair Value $0.0200 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jun 23, 2026.

How to read this chart

60‑month range $0.0010 – $0.2440 · fair‑value band $0.0100 – $0.0200 · the $0.1212 price screens above the $0.0200 fair value. Dashed = 300-day average. As of Jun 23, 2026.

Follow Adia Nutrition in your weekly email

Every Wednesday you see whether Adia Nutrition is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Adia Med Inc offers medical treatments and nutritional supplements. The company operates in three segments: Biolete, Adia Med, and Adia Labs. It provides autologous hematopoietic stem cell transplantation (AHSCT) treatments for multiple sclerosis patients.

Show more

Adia Med Inc offers medical treatments and nutritional supplements. The company operates in three segments: Biolete, Adia Med, and Adia Labs. It provides autologous hematopoietic stem cell transplantation (AHSCT) treatments for multiple sclerosis patients. The company also operates Adia Med, a clinic to perform stem cell treatments, and Adia Labs, which procures and sells stem cell products to outside clinics or Adia Med. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer basis, as well as through other direct to consumer channels. The company was formerly known as Adia Nutrition, Inc. and changed its name to Adia Med Inc in June 2026. Adia Med Inc is based in Winter Park, Florida.

Stock analysis

Adia Nutrition Inc (ADIA) currently trades at $0.1212, while our model-based Fair Value estimate is $0.0200, implying the stock looks roughly 506.1% overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 3 models at a data quality of 95/100, which puts the evidence level at low.

Scenario range: $0.0100 (bear) to $0.0200 (bull), the price of $0.1212 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 44/100 (below-average quality), in the Financial Services sector.

Weak Growth: Revenue growth is weak, negative or inconsistent.

Adia Nutrition Inc reported revenue of $701K in FY2025 versus $415K in FY2002, a compound +2.3%/yr. Reported net income was −$395K in FY2025.

Key figures

Market cap $14.6M · P/S ratio 18.2 · Net margin −56.5% · Return on equity −1,461% · Return on assets (EBIT) −139% · Operating margin −86.2% · Revenue (TTM) $805K · Revenue growth (YoY) +146%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 18 out of 100 (low confidence).

What moves the price

The share trades about 50% below its 52-week high and 385% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Financial Services peers we cover trades at −53% fair-value upside, at −84%, ADIA screens richer than that median.

Notify me when ADIA reaches fair value

Put ADIA on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 44/100

Of which business quality 48 · Market factors (momentum, volatility) 60

Profitability 37
Margins and returns on capital today
Quality Growth 50
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 45
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 59
Price trend over the last 3–12 months (market factor)
52W Momentum 72
Distance to the 52-week high (market factor)
Net Issuance 96
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is weak, negative or inconsistent.
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−110.1% (2002) → −52.3% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
not computed

ADIA screens 506% overvalued. Compare with Lionheart III Corp →

Compare Adia Nutrition Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Shell Companies · 82 stocks

Beats the industry median on 2/7 measures
Overall it trails its industry peers.
Valuation
Quality Score 49 · Above median
Fair Value upside −84% · Bottom 25%
Profitability
Return on equity (TTM) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets −36% · Bottom 25%
Net margin (TTM) −55% · Below median
Operating margin (TTM) −86% · Bottom 25%
Growth and dividend
Revenue growth 146% · Top 25%
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Shell Companies median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (TTM) 18.18× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 24
FUTURE (revenue growth)100 · sector 0
PAST (return on equity)0 · sector 0
HEALTH (low debt)0 · sector 99
DIVIDEND (yield)0 · sector 0

VALUE 0: the price sits above our fair-value range.

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Shell Companies stocks, each showing price versus our Fair Value estimate.

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Adia Nutrition Inc Fair Value". https://www.fairvalue-calculator.com/stock/ADIA

Frequently asked questions

Is Adia Nutrition Inc (ADIA) overvalued or undervalued?
As of Jun 23, 2026, our model estimates a fair value of $0.0200 versus a price of $0.1212, about −84% upside (overvalued).
What is the fair value of ADIA?
Our model-based fair value for Adia Nutrition Inc is $0.0200 (as of Jun 23, 2026), built from audited fundamentals. The current price: $0.1212.
What is the quality score of ADIA?
Adia Nutrition Inc has a Quality Score of 44/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Adia Nutrition Inc (ADIA)?
Our model-based price target is the fair value of $0.0200 (as of Jun 23, 2026) from 3 valuation models. Cautious scenario $0.0100, optimistic scenario $0.0200. It is a calculation from audited fundamentals, not an analyst target.
What is the Adia Nutrition Inc stock forecast for 2026?
Our models put fair value at $0.0200, about −84% upside versus a price of $0.1212 (overvalued). Cautious scenario $0.0100, optimistic scenario $0.0200. The calculation is refreshed regularly with new filings.
What is the revenue of Adia Nutrition Inc (ADIA)?
Adia Nutrition Inc reported trailing-twelve-month revenue of about $805K (latest available figure, as of Jun 23, 2026).
What is the intrinsic value of Adia Nutrition Inc (ADIA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Adia Nutrition Inc it is $0.0200 per share (as of Jun 23, 2026), against a price of $0.1212. It is the blended result of 3 valuation models (cash flow, earnings, asset, dividend).
Is Adia Nutrition Inc stock overvalued or undervalued in 2026?
As of Jun 23, 2026, ADIA trades above its calculated fair value: price $0.1212, fair value $0.0200, a gap of about −84% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ADIA?
No. The price is what the market pays today ($0.1212); the fair value is what the company's own numbers justify ($0.0200). For Adia Nutrition Inc the two are $0.1012 per share apart. That gap is exactly why we show both numbers side by side.
How much is Adia Nutrition Inc worth?
The market values Adia Nutrition Inc at about $14.6M (market capitalisation, as of Jun 23, 2026). Per share that is $0.1212; our models calculate a fair value of $0.0200 per share.
What do the bullish and bearish scenarios say about ADIA?
Our models span a range for Adia Nutrition Inc: cautious scenario $0.0100, base $0.0200, optimistic $0.0200 per share (as of Jun 23, 2026, price $0.1212). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Adia Nutrition Inc (ADIA)?
Balance-sheet figures for Adia Nutrition Inc (as of Jun 23, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 44/100, which measures business quality independently of the share price.
How far is ADIA from its 52-week high?
Adia Nutrition Inc trades at $0.1212, about 50% below its 52-week high of $0.2440 and 385% above the low of $0.0250 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0200 is for.
Which stocks are comparable to Adia Nutrition Inc?
From the same area (Financial Services) we also value Lionheart III Corp, AA Mission Acquisition Corp, Berto Acquisition Corp, Metals Acquisition Corp, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Adia Nutrition Inc stock attractive at the current price?
The data as of Jun 23, 2026: price $0.1212, calculated fair value $0.0200 (−84%), Quality Score 44/100, from 3 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ADIA calculated?
We run Adia Nutrition Inc through 3 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0200, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Adia Nutrition Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Adia Nutrition Inc (ADIA)?
The closing price on Sep 24, 2026 was $0.1212. Our model-based fair value is $0.0200, about −84% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Adia Nutrition Inc right now?
The price sits above even our optimistic bull case ($0.0200). The favourable scenario is already priced in. Weak quality (44/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($0.0100 to $0.0200) leaves room in how you read the outcome.

Key figures of Adia Nutrition Inc

How large is the market capitalisation of Adia Nutrition Inc (ADIA)?
The market capitalisation of Adia Nutrition Inc is $14.6M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Adia Nutrition Inc (ADIA)?
The price-to-sales ratio of Adia Nutrition Inc is 18.2 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Adia Nutrition Inc (ADIA)?
The net margin of Adia Nutrition Inc is −56.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Adia Nutrition Inc (ADIA)?
The return on equity (ROE) of Adia Nutrition Inc is −1,461% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Adia Nutrition Inc (ADIA)?
On an EBIT basis the return on assets of Adia Nutrition Inc is −139% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Adia Nutrition Inc (ADIA)?
The operating margin of Adia Nutrition Inc is −86.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Adia Nutrition Inc (ADIA)?
Revenue at Adia Nutrition Inc is growing +146% versus a year earlier (3y avg −2.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Adia Nutrition Inc (ADIA) generate?
The free cash flow of Adia Nutrition Inc is −$192K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Adia Nutrition Inc (ADIA) carry?
The net debt of Adia Nutrition Inc is $521K (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Adia Nutrition Inc in the live analysis

One click puts Adia Nutrition Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.